Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Capital/Financing Update 2012

Apr 4, 2012

5292_rf_2012-04-04_e47a8785-20b7-4472-a54c-0a8fd40a1059.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

APPLICATION FOR ADMISSION OF SECURITIES TO THE OFFICIAL LIST

Admission to the official list must be simultaneous with admission to trading on an RIE's market for listed securities. You will need to complete a separate application form to apply for trading on a RIE.

† - Indicates a section that is mandatory for all applications. Sections that do not apply should be struck-through as necessary.

To: The FSA

Date: 4 April 2012

Centrica plc (the applicant) hereby applies for the securities described below to be admitted to the official list of the FSA.

Amounts and descriptions of securities for which application is now being made (include distinctive numbers if any). Where the securities are to be issued under a programme, give a description of the programme and the maximum amount (if any) of securities which may be listed at any one time+:

EUR50,000,000 Zero Coupon Notes due 2032

Where application is made for the listing of securities without a prospectus, we confirm that a prospectus is not required pursuant to the Financial Services and Markets Act (the " $Act$ ") for the reasons set out below (please ensure a sufficiently detailed explanation is given as to why the relevant exemptions apply):

Public Offer (quote relevant sub-section of Prospectus
Rule 1.2.2, or relevant part of S85 or S86 of the Act, or
relevant part of Schedule 11A of the Act, and give the
reason for the application of that exemption, or confirm
the transaction falls outside of the scope of the definition
of an offer as defined in the Prospectus Rules ).
N/A
Admission to a regulated market (quote relevant part of
S85 of the Act or the relevant sub-section of Prospectus
Rule 1.2.3, or relevant part of Schedule 11A of the Act,
and give the reason for the application of that exemption).
N/A
Furthermore we confirm that between the date of this application form and the date of
admission we will not take any action that would otherwise require the publication of a
prospectus in respect of the securities the subject of this application.

Where listing particulars would ordinarily be required in respect of the application but have not been prepared please confirm they are not required and the reason(s) why:

$N/A$

The ISIN code(s) for each security to be admitted†: XS0721258860

Type of issue for which application is being made: (for example: placing; rights issue; block listing; issuance programme)†:

Issue of Notes under the U.S.\$8,000,000,000 Euro Medium Term Note Programme

For issuance programme applications, please provide a primary contact(s) at the issuer for correspondence in relation to the programme for which admission is being sought:

$\vert$ Name $(s)$ : Grant Dawson
Position(s): General Counsel & Company Secretary
Email Address(es): [email protected]
Contact Telephone Number(s): 01753 494000

Please confirm which set of standards are applicable to the securities for which application is being made:

Note: For new lines of securities please ensure that the relevant Listing Category has been discussed and agreed with Listing Transactions prior to submitting the application.

Premium (Please tick the relevant box)
Equity Commercial Companies Equity Closed Ended Investment Funds
Equity Open Ended Investment Companies
Standard (Please tick the relevant box)
Shares GDRs
Debt X Securitised Derivatives
MISC Securities

Please specify on which UK market(s) the applicant has applied to have these securities traded+:

Regulated Market of the London Stock Exchange

Please specify where else these securities are, or will be listed and whether the listing(s) are Premium or Standard (if such a distinction is made)†: $N/A$

Which EEA State do you regard as your home member state for the purposes of the Transparency Directive (2004/109/EC?):

Queries in relation to this question should be directed to the Company Monitoring Helpdesk on 020 7066 8333, option 4 Algorithment Communication

United Kingdom
Account/Audit Information*
Accounting Standards used by Issuer International Financial Reporting Standards
Auditing Standards used by Issuer International Standards on Auditing (UK and
Ireland) issued by the Auditing Practices
Board
Information to be provided by a Public Sector Issuer that seeks admission of securities
without a prospectus*
Series Number: N/A
Issue Price: N/A
Specified Denominations: N/A
Issue Date: N/A
Maturity Date: N/A
Form of Securities: N/A
Listing: N/A
ISIN: N/A

*Where this information is already set out in some other document describing the issue (such as final terms) it is sufficient to simply attach that document.

Confirmation

We acknowledge our obligations arising under the listing rules and the legal implications of listing under the Act. Accordingly, we confirm that:

  • all the requirements for listing in the listing rules, which are required to be fulfilled $11$ before the application is to be considered, have been fulfilled in relation to the issuer and the securities for which application is now made (save where otherwise agreed with the $FSA$ );
  • $2,$ all the documents and information required to be included in the application have been or will be supplied in line with the listing rules, and all other requirements of the FSA in respect of the application have been or will be complied with.
  • we undertake to comply with the listing rules so far as applicable to the issuer. 3,
  • 4, we acknowledge the obligation to comply with the requirement to publish a supplementary prospectus or supplementary listing particulars if, at any time after a prospectus or listing particulars have been approved such document would be required by the Act, the Prospectus Rules or the Listing Rules.
  • 5, on admission the securities for which application has been made will be allotted (for equity securities) and in issue (for debt securities) pursuant to the appropriate board resolutions and with the appropriate authority (save in circumstances where the FSA has specifically agreed otherwise including inter alia block listings, applications by open-ended investment companies, applications for the admission of 'up to' amounts).

SIGNED BY †

Mull

Director/company secretary/suitably experienced employee/duly authorised officer, for and on behalf of:

Centrica plc Name of applicant

Application to be heard on † 4 April 2012
Admission expected to be effective on : 5 April 2012
Admission expected to be effective on†: 5 April 2012
Name(s) of contact(s) at applicant
regarding the application†:
Grant Dawson
Telephone number(s) of contact(s) at
$\mid$ applicant regarding the application†:
01753 494000